TABLE 2.

A comparison of community-acquired pneumonia symptom (CAP-sym) values with the CAP-sym validation cohort

Clinical stage	CAP-sym score mean±sd
	This study (n=169)	Torreset al. [19]
		Standard treatment (n=244)	Moxifloxacin (n=233)
Pre-pneumonia	13.6±14.5	NA	NA
Enrolment	32.8±14.6	33.9±13.6	34.3±13.2
Mid-treatment	23.8±15.1	20.6±11.0	20.9±11.8
Discharge	15.3±10.6	12.0±10.3	13.5±11.5
Early follow-up	13.6±11.8	9.6±10.8	10.1±10.9
Medium-term follow-up	12.6±11.8	NA	NA
Late follow-up	13.3±12.7	NA	NA

Mid-treatment in this study was 48 h after enrolment, while in the study by Torres et al. [19] it was between days 3 and 5. Discharge in this study is equivalent to the 7–10 day “test of cure” time point in the study by Torres et al. [19]. Early follow-up in this study was at 28 days, while in the study by Torres et al. [19] it was between days 28 and day 35. NA: not available.